Welcome to the CENTOGENE Booth
Explore our latest innovations in Guiding Precision Medicine and download ⇢ key materials right from this page or get to know ⇢ our team on side.
@Booth #348
⏲
Looking for a different time?
Feel free to stop by the booth to check for additional slots – we’re happy to accommodate when possible!
| 12.45–13.15 | P08.007.A | Luba Pardo Niemann-Pick disease type C2: genetic, phenotypic and biomarker insights from a cohort of 41 patients P17.043.A | Javier Garcia-Planells Prevention of non-communicable diseases: impact of P/LP variants in ACMG actionable genes in an ethnically diverse population cohort of 102,704 individuals P20.115.A | Mukunth Sadagapan Biallelic pathogenic variants in the DST-b isoform cause autosomal recessive congenital myopathy and highlight the importance of isoform-specific interpretation P20.169.A | Kridsadakorn Chaichoompu Evaluation of Ultima Genomics genome sequencing in rare disease diagnostic settings |
| 16.00–17.00 | P20.158.B | Mandy Radefeldt Pathogenic RNU4-2variants are identified in ~1.7% of exome-negative neurodevelopmental disorder patients enriched for relevant phenotypic features |
| 12:45–13.45 | P03.003.C | Boodor Al-Kawlani Expanding the clinical spectrum of prenatal-onset recessive titinopathy |
| 15:45–16.45 | P20.184.D | Daniel Polla Enhancing variant interpretation in rare diseases: Integrating RNA-seq splicing and expression analysis with DNA-seq based diagnostics using DBS cards |
| 12:45–13.45 | P01.065.E | Moneeb Othman Application of ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines v3.1 for Germline Variant Reclassification: Insights from a Single-Center Cohort. P20.047.E | Martin Shumanov Enhancing rare disease diagnostics by functional assessment of DNA Variants Using RNA sequencing from dried blood spots P20.167.E | Kridsadakorn Chaichoompu Diagnostic potential of Oxford Nanopore sequencing from dried blood spots for complex rare‑disease variants P20.203.E | Lova S Masta Founder Deep Intronic LZTR1 Variant Causing Autosomal Recessive Noonan Syndrome: Genome and RNA Sequencing Findings from a Kuwaiti Familial Cohort |
| 15:45–16.45 | P13.012.F | Florencia Bevilacqua Expanding the Clinical and Molecular Spectrum of SETD2-Related Disorders: Insights from 35 New Patients P20.090.F | Antonio Romito RNA sequencing as a complementary diagnostic tool for the identification and functional evaluation of structural variants P20.114.F | Aida Bertoli-Avella 15:45–16.15 – Lightning Talks Stage 1 Challenging Dominance: Evidence for Biallelic Disease in Traditionally Autosomal Dominant Genes |
Meet Our Sales Team @Booth #348
Victor Llinares
Chief Commercial Officer
Ana Esteban
VP Marketing & Customer Experience
Mar Lozano
Marketing Coordinator
Luis Aznar
VP Sales South Europe
Giovanni Zifarelli
Senior Director Business Development
Damaso Mazuelos
Head of Sales Iberia
Martin Shumanov
Head of Sales Northern Europe
Rifat Cenk Misirlioglu
Head of Sales East Mediterranean Europe
Miltiadis Sofianopoulos
Regional Manager Greece & Cyprus
Tanya Slavova
Regional Manager Eastern Europe
Marcin Kaleba
Regional Manager Eastern Europe Central North
Arianda Abazi
Regional Manager Nordics
Agua Sobrino
Regional Manager UK and Ireland
Meet Our Scientific Team @Booth #348
Peter Bauer
Chief Medical and Genomic Officer
Krishna Kumar Kandaswamy
Chief Technology Officer
Jorge Pinto-Basto
VP Medical Genetics
Javier Garcia Planells
VP Medical Affairs and Product Development
Christian Beetz
Senior Director Genomic Innovation
Lia Abbasi Moheb
Senior Director of Diagnostic Department
Aida Bertoli-Avella
Director of Medical Genetics & Genomic Research
Eleni Perraki
Senior Product Manager
Alejandra Reyes
Head of Medical Evaluation
Lova Satyanarayana Matsa
Clinical Genetic Liaison & Lab Director UAE / Sales Manager
Antonio Romito
Senior Scientist
Mandy Radefeldt
Senior Scientist Data Insights
Boodor Al-Kawlani
Supervisor Clinical Reporting
Emir Zonic
Senior Classification & Curation Scientist
Moneeb Othman
Supervisor Clinical Reporting
Daniel Polla
Supervisor Clinical Reporting
Nayla León Carlos
Human Geneticist
Florencia Bevilacqua
Medical Expert
Kridsadakorn Chaichoompu
Senior Bioinformatician
Mukunth Sadagapan
IT Project Manager
Comprehensive Genetic Testing Across the Cancer Care Management
Customizable testing solution that enables physicians to have the flexibility to create a gene panel tailored to each patient’s clinical needs. #YourPatientYourChoice
Whole Genome Sequencing (WGS), offers the most comprehensive one-step solution with the highest diagnostic yield
Whole Exome Sequencing (WES) enables quicker and cost-effective diagnosis for patients with complex and unclear symptoms
Multiomics give a deeper understanding of human biological processes and acts as a unique and highly effective tool for early diagnosis
Our NGS panel portfolio tests for a wide selection of hereditary genetic conditions offering a fast, thorough, and cost-effective diagnostic tool for patients with distinctive clinical features.
Non-invasive prenatal test (NIPT) that screens for the most common fetal chromosomal abnormalities – combining the latest NGS technology with expert medical reporting.
